Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Jim Watson/AFP via Getty Images

The Biden campaign called on President Trump on Tuesday to answer three specific questions before releasing a coronavirus vaccine, while simultaneously warning that Trump may seek to short-circuit the scientific process for the sake of his re-election. 

Why it matters: After Trump accused Joe Biden and Kamala Harris of being anti-vaxxers yesterday, the Biden campaign is trying to establish firm standards on what would allay its fears that Trump isn't accelerating a vaccine for political reasons. 

  • "The concern is not about the vaccine. The concern is about the president interfering in the process, into the scientific process,” Dr. David Kessler, a former FDA commissioner and a Biden adviser, said on a conference call with reporters.
  • "Any vaccine must be a product of science and research," said Symone Sanders, a top Biden adviser.

The three vaccine standards advocated by the Biden campaign:

  • What criteria will be used to ensure that any vaccine meets the scientific standard of safety and efficacy.
  • Who will validate that those standards were met.
  • What is the plan to distribute the vaccine cost-free and safely.

The big picture: Trump has hinted that a vaccine could arrive before the election, raising concerns among Democrats that the vaccine either won’t be effective or won’t be trusted by large sections of the American public.

  • During an AFL-CIO virtual town hall yesterday, Biden told union members not to trust Trump on the vaccine.

Go deeper

Scoop: Vice President Pence to receive televised vaccine shot

Vice President Mike Pence. Photo: SOPA Images / Getty Images

Vice President Mike Pence plans to receive his coronavirus vaccine shot on camera Friday morning at the White House to build "vaccine confidence" among the American people, according to an administration official with direct knowledge of the plans.

Driving the news: Details are still being worked out, but Pence wants the TV networks to carry the moment live in the morning, the source said, to maximize the audience for the vaccination.

Dec 17, 2020 - Health

Extra doses of Pfizer vaccine could expand U.S. supply

An infectious disease doctor in California receives the Pfizer vaccine on Thursday, Dec. 17. Photo: Keith Birmingham/MediaNews Group/Pasadena Star-News via Getty

Pfizer vaccine vials contain extra doses that could boost America's supply by up to 40%, the Food and Drug Administration announced on Wednesday.

Driving the news: The U.S. has 100 million doses of the Pfizer-BioNTech vaccine to inoculate 50 million people but declined to buy more doses earlier this year. The vaccine is first being administrated to frontline health care workers and nursing home residents and staff.

Updated 41 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Health: Most vulnerable Americans aren't getting enough vaccine information — Fauci says Trump administration's lack of facts on COVID "very likely" cost lives.
  2. Education: Schools face an uphill battle to reopen during the pandemic.
  3. Vaccine: Florida requiring proof of residency to get vaccine — CDC extends interval between vaccine doses for exceptional cases.
  4. World: Hong Kong puts tens of thousands on lockdown as cases surge — Pfizer to supply 40 million vaccine doses to lower-income countries — Brazil begins distributing AstraZeneca vaccine.
  5. Sports: 2021 Tokyo Olympics hang in the balance.
  6. 🎧 Podcast: Carbon Health's CEO on unsticking the vaccine bottleneck.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!